Paclitaxel
NDC 75007-041, Paclitaxel (aibumin-bound), injection, powder, lyophilized, for suspension, from Ningbo Shuangcheng Pharmaceutical Co., Ltd.
- Product NDC
- 75007-041
- Status
- Listed
- Labeler
- Ningbo Shuangcheng Pharmaceutical Co., Ltd
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216355
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75007-041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PACLITAXEL100 mg/100mg
Pharmacologic classes
Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/4df3fda6-0b29-420e-ab91-81441ce914ed
Use it
Look up 75007-041 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75007-041 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75007-041. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.